If ever an industry was in need of both incremental and disruptive innovation, it is today’s healthcare industry. Realizing the full potential of innovation across the spectrum of healthcare environments is critical to address the well-documented, emerging global crisis generated by the aging of the population, the obligation to increase access for all to the best standard of care, and the societal imperative to contain costs. In addition, as budgets at funders such as the National Institutes of Health (NIH, USA), the National Health Service (NHS, UK) and others are increasingly constrained, it is more important than ever to increase the efficiency and effectiveness with which investments in fundamental research and development translate into products, services, and procedures that improve the health and well being of people around the world.
Dr. Steven Schachter is Chief Academic Officer and Program Leader of NeuroTechnology at Boston’s Consortia for Improving Medicine with Innovation and Technology (CIMIT) and a Professor of Neurology at Harvard Medical School (HMS). He is Past President of the American Epilepsy Society. He serves on the Epilepsy Foundation Board of Directors and has directed over 70 research projects involving antiepileptic therapies, published over 200 articles and chapters, compiled the Brainstorms series, which has been distributed to over 150,000 patients and families worldwide in several languages, and edited or written 30 other books on epilepsy and behavioral neurology. Dr. Schachter is the founding editor and editor-in-chief of the medical journals Epilepsy & Behavior and Epilepsy & Behavior Case Reports.